Search | Clinical Trials Finder

Conditions: Cardiovascular Diseases, Metabolic Disease, Peripheral Artery Disease, Carotid Disease, Aneurysmal Disease, Venous Disease, Thrombosis, Lymphedema, Lipedema, Non-Atherosclerotic Chronic Arterial Occlusive Disease, Vasculitis, Fibromuscular Dysplasia, Arterial Dissection, May-Thurner Syndrome, Thoracic Outlet Syndrome, Vasospasm
Interventions: Not listed
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Timeline: 2019 – 2031
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Brain Tumor, Stroke, Acute, Brain Aneurysm, Intracranial Arteriovenous Malformations, Carotid Stenosis, Cavernous Sinus Thrombosis
Interventions: Transradial approach; Device
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Acute Venous and Arterial Thrombotic and Thromboembolic Events, Healthy Volunteers
Interventions: BAY3018250 Dose 1, Placebo, BAY3018250 Dose 2 infusion, BAY3018250 Dose 2 injection; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Los Alamitos, California

Conditions: Compression; Vein, Compression; Artery, Sedentary Behavior, DVT of Legs
Interventions: Lower extremity compression garments, Active break; Device · Behavioral
Lead sponsor: New York Institute of Technology; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Old Westbury, New York

Conditions: Coronary Artery Disease, Aortic Aneurysm, Pulmonary Embolism
Interventions: Not listed
Lead sponsor: Gilbert L. Raff, MD; Other
Eligibility: 18 Years and older
Enrollment: 2,640 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 8
States / cities: San Diego, California • Boston, Massachusetts • Royal Oak, Michigan + 5 more

Conditions: Glaucoma, Glaucoma Suspect, Diabetic Retinopathy, Ocular Hypertension, Cataract, Branch Retinal Vein Occlusion, Branch Retinal Arterial Occlusion, Central Retinal Vein Occlusion, Central Retinal Artery Occlusion, Epi-retinal Membrane, Macular Degeneration, Drusen, Loss of Vision
Interventions: Free Eye Screenings, Enhanced Intervention, Usual Care; Other
Lead sponsor: Wills Eye; Other
Eligibility: 40 Years and older
Enrollment: 906 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Thromboembolism
Interventions: Apixaban; Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 1 Day to 18 Years
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2020
U.S. locations: 18
States / cities: Little Rock, Arkansas • Orange, California • Hartford, Connecticut + 13 more

Conditions: COVID-19, Venous Thromboses, Arterial Thrombosis
Interventions: Enoxaparin Prophylactic Dose, Heparin Infusion, Heparin SC, Enoxaparin/Lovenox Intermediate Dose; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Venous Embolism of Lower Extremities (Diagnosis), Arterial Embolism and Thrombosis, Acute DVT of Lower Extremity, Chronic DVT of Lower Extremity, DVT, Deep Vein Thrombosis Leg, Thrombus in the Peripheral Venous Vasculature, Peripheral Arterial Disease, Acute Limb Ischemia, Lower Extremity Acute Limb Ischemia, LE ALI
Interventions: Liberant Thrombectomy System; Device
Lead sponsor: Medtronic Endovascular; Industry
Eligibility: 22 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 4
States / cities: Washington D.C., District of Columbia • Naples, Florida • New York, New York + 1 more

Conditions: Thrombosis; Artery
Interventions: Ticagrelor Oral Tablet [Brilinta]; Drug
Lead sponsor: George Washington University; Other
Eligibility: 18 Years to 70 Years
Timeline: 2020
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Fairfax, Virginia

Conditions: Renal Artery Obstruction, Kidney Disease
Interventions: MRI; Procedure
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: Not listed
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2005
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Stroke
Interventions: IV rt-PA alone, endovascular therapy; Drug · Other
Lead sponsor: Joseph Broderick; Other
Eligibility: 18 Years to 82 Years
Enrollment: 656 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 49
States / cities: Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 39 more

Conditions: Pulmonary Embolism
Interventions: Vertex Pulmonary Embolectomy System; Device
Lead sponsor: Jupiter Endovascular; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 123 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 18
States / cities: Hartford, Connecticut • Pensacola, Florida • Atlanta, Georgia + 13 more

Conditions: Acute Myocardial Infarction, Restenoses, Coronary, Coronary Artery Lesions, Venous Embolism, Arterial Embolism
Interventions: Coronary and peripheral stents, Pacing catheters, Vascular plugs, Measurement and imaging (FFR and OCT), Peripheral dilatation catheters, Coronary dilatation catheters, Coronary and peripheral guidewires, Vessel closure/compression devices, Vascular access introducers; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 3,784 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2031
U.S. locations: 7
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Los Angeles, California + 4 more

Conditions: Coronary Artery Bypass Grafting, Postoperative Atrial Fibrilation, Stroke, Systemic Embolism, Deep Venous Thrombosis
Interventions: Apixaban, Warfarin; Drug
Lead sponsor: Sanford Health; Other
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Fargo, North Dakota

Conditions: Coronary Artery Disease, Coronary Thrombosis
Interventions: Medtronic Endeavor Stent, Reduced duration (6 months) DAPT; Device · Drug
Lead sponsor: Scripps Health; Other
Eligibility: 18 Years and older
Enrollment: 219 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Atherosclerosis, Healthy
Interventions: [C-11]PBR28; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 89 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 2
States / cities: Bethesda, Maryland

Conditions: Chest Pain, Acute Coronary Syndrome, Pulmonary Embolism, Aortic Dissection
Interventions: Not listed
Lead sponsor: University of Washington; Other
Eligibility: 30 Years and older
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Acute Coronary Syndrome, Myocardial Infarction, Coronary Artery Disease, Percutaneous Coronary Intervention
Interventions: CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin, Plavix (clopidogrel 75 mg) and aspirin; Drug
Lead sponsor: Cogentus Pharmaceuticals; Industry
Eligibility: 21 Years and older
Enrollment: 5,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 247
States / cities: Alexander City, Alabama • Birmingham, Alabama • Geneva, Alabama + 205 more

Conditions: Acute Ischemic Stroke
Interventions: Intra-arterial Tenecteplase, Intra-arterial Saline; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Heart Defects, Congenital
Interventions: Clopidogrel (SR25990), placebo; Drug
Lead sponsor: Sanofi; Industry
Eligibility: Up to 92 Days
Enrollment: 906 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Carotid Stenosis, Carotid Artery Diseases
Interventions: Neuroguard IEP Direct System; Device
Lead sponsor: Contego Medical, Inc.; Industry
Eligibility: 20 Years to 82 Years
Enrollment: 178 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 30
States / cities: Scottsdale, Arizona • Hartford, Connecticut • Washington D.C., District of Columbia + 25 more

Conditions: Intracranial Embolism, Cerebral Thromboembolism, Carotid Stenosis
Interventions: ARC1779 Injection, Placebo (normal saline); Drug
Lead sponsor: Archemix Corp.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 2
States / cities: Hackensack, New Jersey • Houston, Texas

Conditions: Thrombosis
Interventions: alteplase; Drug
Lead sponsor: University of Louisville; Other
Eligibility: 28 Weeks to 66 Weeks
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2012
U.S. locations: 1
States / cities: Louisville, Kentucky

Search by objective public record fields.

Vascular Lab Resource (VLR) Biorepository

Safety and Feasibility of the Infinity Catheter for Radial Access

A Study to Learn About How Safe BAY3018250 is and What Happens to it in Healthy Japanese Men and Adult Participants Aged 18 to 55 Years

Lower Leg Compression in Extended Video Game Play: A Pilot Study

Computed Tomography Dose Reduction Using Sequential or Fast Pitch Sprial Technique

Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study

Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic Disorder

Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19

Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System

Impact of Anti-platelet Drug Exposure on Platelet mRNA Splicing in Healthy Subjects

MRI to Detect Embolism Following Angiography and Angioplasty-Stenting of the Renal Artery

Interventional Management of Stroke (IMS) III Trial

Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-II

Abbott Vascular Medical Device Registry

Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation

Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside)

PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Carotid Atherosclerosis

Diagnostic Accuracy of Multislice CT Angiography for Acute Chest Pain

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)

Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Stroke

Efficacy And Safety Of Clopidogrel In Neonates /Infants With Systemic To Pulmonary Artery Shunt Palliation

Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)

Effect of ARC1779 on Cerebral Microembolism in Patients Undergoing Carotid Endarterectomy

Safety and Efficacy of Tissue Plasminogen Activator (tPA) in Neonates and Infants